Advertisement Community Bridges completes Hythiam's Prometa drug abuse program - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Community Bridges completes Hythiam’s Prometa drug abuse program

Community Bridges has completed a pilot program to assess the medical component of Hythiam's Prometa Treatment Program as a comparison to their standard ASAM medical detoxification protocol for Medicaid-eligible adults seeking treatment for Methamphetamine abuse.

The pilot program included 100 participants (50 in the PTP group and 50 in a control group). Patients were evaluated for program participation eligibility by Community Bridges treatment staff and given a medical assessment. Individuals seeking treatment for methamphetamine dependency at Community Bridges were offered the option to receive the standard ASAM medical detox protocol or to participate in the pilot and receive PTP as their detox protocol.

The first 50 qualified individuals who volunteered for PTP were provided PTP as the medical portion of their detox protocol and offered an opportunity to participate in the Matrix Model Intensive Outpatient Therapy upon completion of detox. The control group of 50 Medicaid-eligible applicants for detox treatment chose not to participate in the PTP detox but volunteered to receive the standard ASAM-recommended medical detox protocol.

The group receiving the PTP demonstrated a higher rate of retention in detox over those receiving the ASAM standard of care treatment, and a reduction in cravings over the 16 week Intensive Outpatient Therapy period.